Showing results (141-150 of 193) with videos related to
Sort By:
Pageof 20
Scientific Reports|October 9, 2015
Hetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activitiesLi-Qiang Pan, Wen-Bin Zhao, Jun Lai, et al.Plos One|April 23, 2016
Sequencer-Based Capillary Gel Electrophoresis (SCGE) Targeting the rDNA Internal Transcribed Spacer (ITS) Regions for Accurate Identification of Clinically Important Yeast SpeciesXin Hou, Meng Xiao, Sharon C-A Chen, et al.Journal of Cancer Research and Clinical Oncology|March 5, 2016
Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trialYing-Chun Xu, Qi Xu, Jun-Jian Li, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 18, 2019
Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospitalYao Wang, Xin-Fei Chen, Xiu-Li Xie, et al.Future Microbiology|December 13, 2022
Study of an antifungal medicine isavuconazole used in treatment of mold infections in China: A plain language summaryRan Jing, Ian Morrissey, Meng Xiao, et al.Infection and Drug Resistance|May 2, 2022
In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in ChinaRan Jing, Ian Morrissey, Meng Xiao, et al.Chinese Medical Journal|November 2, 2010
In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofunginJun-yan Shi, Ying-chun Xu, Yi Shi, et al.Oncology Reports|August 8, 2015
RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patientsYing-Chun Xu, Feng-Chun Zhang, Jun-Jian Li, et al.Frontiers in Microbiology|March 19, 2020
In vitro Activity of a New Fourth-Generation Cephalosporin, Cefoselis, Against Clinically Important Bacterial Pathogens in ChinaJing-Wei Cheng, Jian-Rong Su, Meng Xiao, et al.Pageof 20